Polyrizon Ltd. Competitors

Veeva delivers the industry cloud for life sciences with software, AI, data, and business consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world’s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com. Correspondence to new applicants and existing candidates will only come from an official @veeva.com email address.

At Revolution Medicines, we aim to change the trajectory of disease for patients living with RAS-addicted cancers around the world. We challenge assumptions, act on what the science reveals, and push beyond convention to tackle some of the most difficult-to-treat cancers. Our differentiated, platform-driven approach targets RAS in its active, ON state—unlocking a fundamentally new way to inhibit RAS. We are advancing a broad, integrated pipeline of inhibitors with the ambition to establish RAS(ON) inhibition as the backbone for treating RAS-addicted cancers while continuing to pioneer the next generation of innovation. We follow the science and act on it with urgency to turn insights into new treatments—because for patients, the stakes are deeply personal, measured in time and quality of life.

Our products and behaviour affect and improve the health and well-being of millions of patients, and their families around the world. Our customers entrust us with the responsibility to deliver life-saving or life-enhancing products. We come to work every day to serve these customers, but ultimately, because we passionately care about their patients. The Aenova Group is one of the leading companies in the global pharmaceutical and healthcare industry. The group’s portfolio of services covers the entire value chain for the development and production of all the main dosage forms and product groups in the field of medicines and dietary supplements. The Aenova Group’s high standards of quality, innovative technologies and clear vision for the future have enabled it to become European market leader in the business-to-business field. The company, which has its headquarters near Munich, operates 14 sites throughout the world. Around 4,000 employees contribute to the group’s success. www.aenova-group.com Imprint: https://www.aenova-group.com/en/imprint Privacy policy social media: https://www.aenova-group.com/en/privacy/privacy-policy-social-media